IBDEI0J7 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8640,1,3,0)
;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
;;^UTILITY(U,$J,358.3,8640,1,4,0)
;;=4^D75.89
;;^UTILITY(U,$J,358.3,8640,2)
;;=^5002392
;;^UTILITY(U,$J,358.3,8641,0)
;;=D47.Z9^^39^401^182
;;^UTILITY(U,$J,358.3,8641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8641,1,3,0)
;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
;;^UTILITY(U,$J,358.3,8641,1,4,0)
;;=4^D47.Z9
;;^UTILITY(U,$J,358.3,8641,2)
;;=^5002262
;;^UTILITY(U,$J,358.3,8642,0)
;;=D05.82^^39^401^39
;;^UTILITY(U,$J,358.3,8642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8642,1,3,0)
;;=3^Carcinoma in Situ Left Breast,Other Spec Type
;;^UTILITY(U,$J,358.3,8642,1,4,0)
;;=4^D05.82
;;^UTILITY(U,$J,358.3,8642,2)
;;=^5001934
;;^UTILITY(U,$J,358.3,8643,0)
;;=D05.81^^39^401^41
;;^UTILITY(U,$J,358.3,8643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8643,1,3,0)
;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
;;^UTILITY(U,$J,358.3,8643,1,4,0)
;;=4^D05.81
;;^UTILITY(U,$J,358.3,8643,2)
;;=^5001933
;;^UTILITY(U,$J,358.3,8644,0)
;;=D05.80^^39^401^43
;;^UTILITY(U,$J,358.3,8644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8644,1,3,0)
;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
;;^UTILITY(U,$J,358.3,8644,1,4,0)
;;=4^D05.80
;;^UTILITY(U,$J,358.3,8644,2)
;;=^5001932
;;^UTILITY(U,$J,358.3,8645,0)
;;=D56.8^^39^401^205
;;^UTILITY(U,$J,358.3,8645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8645,1,3,0)
;;=3^Thalassemias,Other
;;^UTILITY(U,$J,358.3,8645,1,4,0)
;;=4^D56.8
;;^UTILITY(U,$J,358.3,8645,2)
;;=^5002305
;;^UTILITY(U,$J,358.3,8646,0)
;;=C82.89^^39^401^81
;;^UTILITY(U,$J,358.3,8646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8646,1,3,0)
;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
;;^UTILITY(U,$J,358.3,8646,1,4,0)
;;=4^C82.89
;;^UTILITY(U,$J,358.3,8646,2)
;;=^5001540
;;^UTILITY(U,$J,358.3,8647,0)
;;=D51.8^^39^401^212
;;^UTILITY(U,$J,358.3,8647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8647,1,3,0)
;;=3^Vitamin B12 Deficiency Anemias,Other
;;^UTILITY(U,$J,358.3,8647,1,4,0)
;;=4^D51.8
;;^UTILITY(U,$J,358.3,8647,2)
;;=^5002288
;;^UTILITY(U,$J,358.3,8648,0)
;;=I80.9^^39^401^187
;;^UTILITY(U,$J,358.3,8648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8648,1,3,0)
;;=3^Phlebitis/Thrombophlebitis,Unspec Site
;;^UTILITY(U,$J,358.3,8648,1,4,0)
;;=4^I80.9
;;^UTILITY(U,$J,358.3,8648,2)
;;=^93357
;;^UTILITY(U,$J,358.3,8649,0)
;;=D45.^^39^401^188
;;^UTILITY(U,$J,358.3,8649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8649,1,3,0)
;;=3^Polycythemia Vera
;;^UTILITY(U,$J,358.3,8649,1,4,0)
;;=4^D45.
;;^UTILITY(U,$J,358.3,8649,2)
;;=^96105
;;^UTILITY(U,$J,358.3,8650,0)
;;=C77.3^^39^401^117
;;^UTILITY(U,$J,358.3,8650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8650,1,3,0)
;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
;;^UTILITY(U,$J,358.3,8650,1,4,0)
;;=4^C77.3
;;^UTILITY(U,$J,358.3,8650,2)
;;=^5001330
;;^UTILITY(U,$J,358.3,8651,0)
;;=C77.2^^39^401^133
;;^UTILITY(U,$J,358.3,8651,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8651,1,3,0)
;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
;;^UTILITY(U,$J,358.3,8651,1,4,0)
;;=4^C77.2
;;^UTILITY(U,$J,358.3,8651,2)
;;=^267316
;;^UTILITY(U,$J,358.3,8652,0)
;;=C77.1^^39^401^134
;;^UTILITY(U,$J,358.3,8652,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0J7 3749 printed Apr 09, 2024@21:20:31 Page 2
IBDEI0J7 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8640,1,3,0)
+2 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
+3 ;;^UTILITY(U,$J,358.3,8640,1,4,0)
+4 ;;=4^D75.89
+5 ;;^UTILITY(U,$J,358.3,8640,2)
+6 ;;=^5002392
+7 ;;^UTILITY(U,$J,358.3,8641,0)
+8 ;;=D47.Z9^^39^401^182
+9 ;;^UTILITY(U,$J,358.3,8641,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,8641,1,3,0)
+12 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
+13 ;;^UTILITY(U,$J,358.3,8641,1,4,0)
+14 ;;=4^D47.Z9
+15 ;;^UTILITY(U,$J,358.3,8641,2)
+16 ;;=^5002262
+17 ;;^UTILITY(U,$J,358.3,8642,0)
+18 ;;=D05.82^^39^401^39
+19 ;;^UTILITY(U,$J,358.3,8642,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,8642,1,3,0)
+22 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
+23 ;;^UTILITY(U,$J,358.3,8642,1,4,0)
+24 ;;=4^D05.82
+25 ;;^UTILITY(U,$J,358.3,8642,2)
+26 ;;=^5001934
+27 ;;^UTILITY(U,$J,358.3,8643,0)
+28 ;;=D05.81^^39^401^41
+29 ;;^UTILITY(U,$J,358.3,8643,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,8643,1,3,0)
+32 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
+33 ;;^UTILITY(U,$J,358.3,8643,1,4,0)
+34 ;;=4^D05.81
+35 ;;^UTILITY(U,$J,358.3,8643,2)
+36 ;;=^5001933
+37 ;;^UTILITY(U,$J,358.3,8644,0)
+38 ;;=D05.80^^39^401^43
+39 ;;^UTILITY(U,$J,358.3,8644,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,8644,1,3,0)
+42 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
+43 ;;^UTILITY(U,$J,358.3,8644,1,4,0)
+44 ;;=4^D05.80
+45 ;;^UTILITY(U,$J,358.3,8644,2)
+46 ;;=^5001932
+47 ;;^UTILITY(U,$J,358.3,8645,0)
+48 ;;=D56.8^^39^401^205
+49 ;;^UTILITY(U,$J,358.3,8645,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,8645,1,3,0)
+52 ;;=3^Thalassemias,Other
+53 ;;^UTILITY(U,$J,358.3,8645,1,4,0)
+54 ;;=4^D56.8
+55 ;;^UTILITY(U,$J,358.3,8645,2)
+56 ;;=^5002305
+57 ;;^UTILITY(U,$J,358.3,8646,0)
+58 ;;=C82.89^^39^401^81
+59 ;;^UTILITY(U,$J,358.3,8646,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,8646,1,3,0)
+62 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
+63 ;;^UTILITY(U,$J,358.3,8646,1,4,0)
+64 ;;=4^C82.89
+65 ;;^UTILITY(U,$J,358.3,8646,2)
+66 ;;=^5001540
+67 ;;^UTILITY(U,$J,358.3,8647,0)
+68 ;;=D51.8^^39^401^212
+69 ;;^UTILITY(U,$J,358.3,8647,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,8647,1,3,0)
+72 ;;=3^Vitamin B12 Deficiency Anemias,Other
+73 ;;^UTILITY(U,$J,358.3,8647,1,4,0)
+74 ;;=4^D51.8
+75 ;;^UTILITY(U,$J,358.3,8647,2)
+76 ;;=^5002288
+77 ;;^UTILITY(U,$J,358.3,8648,0)
+78 ;;=I80.9^^39^401^187
+79 ;;^UTILITY(U,$J,358.3,8648,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,8648,1,3,0)
+82 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
+83 ;;^UTILITY(U,$J,358.3,8648,1,4,0)
+84 ;;=4^I80.9
+85 ;;^UTILITY(U,$J,358.3,8648,2)
+86 ;;=^93357
+87 ;;^UTILITY(U,$J,358.3,8649,0)
+88 ;;=D45.^^39^401^188
+89 ;;^UTILITY(U,$J,358.3,8649,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,8649,1,3,0)
+92 ;;=3^Polycythemia Vera
+93 ;;^UTILITY(U,$J,358.3,8649,1,4,0)
+94 ;;=4^D45.
+95 ;;^UTILITY(U,$J,358.3,8649,2)
+96 ;;=^96105
+97 ;;^UTILITY(U,$J,358.3,8650,0)
+98 ;;=C77.3^^39^401^117
+99 ;;^UTILITY(U,$J,358.3,8650,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,8650,1,3,0)
+102 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
+103 ;;^UTILITY(U,$J,358.3,8650,1,4,0)
+104 ;;=4^C77.3
+105 ;;^UTILITY(U,$J,358.3,8650,2)
+106 ;;=^5001330
+107 ;;^UTILITY(U,$J,358.3,8651,0)
+108 ;;=C77.2^^39^401^133
+109 ;;^UTILITY(U,$J,358.3,8651,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,8651,1,3,0)
+112 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
+113 ;;^UTILITY(U,$J,358.3,8651,1,4,0)
+114 ;;=4^C77.2
+115 ;;^UTILITY(U,$J,358.3,8651,2)
+116 ;;=^267316
+117 ;;^UTILITY(U,$J,358.3,8652,0)
+118 ;;=C77.1^^39^401^134
+119 ;;^UTILITY(U,$J,358.3,8652,1,0)
+120 ;;=^358.31IA^4^2
